Friday, July 10, 2026

Drug profile · INN

vorapaxar

vorapaxar (ZONTIVITY) is a proteinase-activated receptor 1 antagonist.

EMA: withdrawn Blood and blood forming organs (B01) B01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — vorapaxar
Class
Blood and blood forming organs (B01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

vorapaxar (ZONTIVITY) is a proteinase-activated receptor 1 antagonist.

Key facts

INN vorapaxar
Brand ZONTIVITY
Mechanism Proteinase-activated receptor 1 antagonist
Therapeutic class Blood and blood forming organs (B01)
ATC code B01

Mechanism of action

Proteinase-activated receptor 1 antagonist

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is vorapaxar?

vorapaxar (ZONTIVITY) is a proteinase-activated receptor 1 antagonist.

What is the brand name for vorapaxar?

ZONTIVITY is a marketed brand name for vorapaxar. Check FDA Drugs@FDA for the current US label holder and prescribing information.